v3.26.1
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION
6 Months Ended
Jun. 27, 2026
Equity [Abstract]  
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION

10. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION

 

Registered sale of equity securities

 

On September 29, 2025, the Company entered into a securities purchase agreement (the “Purchase Agreement”) for a private investment in public equity financing (the “PIPE”) for 19,545,950 shares of its common stock, par value $0.01 per share (the “Shares”). The net proceeds to the Company from the offering were approximately $38.1 million, after deducting placement agent fees and commissions and offering expenses payable by the Company. The transaction was consummated on September 30, 2025.

 

 

Non-Vested Restricted Common Stock

 

Restricted stock activity for the six-month period ended June 27, 2026 was as follows:

 

   Shares   Weighted
Average
Grant-Date
Fair Value
   Grant-Date
Fair Value
 
Non-vested at December 27, 2025   5,339,847   $1.41   $7,551,683 
Granted   1,578,773    2.97   $4,682,140 
Forfeited   (384,050)   1.50   $(575,086)
Vested   (1,280,525)   1.38   $(1,767,571)
Non-vested at June 27, 2026   5,254,045   $1.88    9,891,166 
Expected to vest   5,254,045   $1.88   $9,891,166 

 

Stock-Based Compensation

 

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock and stock options awards for the three and six months ended June 27, 2026 and June 28, 2025 (no tax benefits were recognized):

 

   Three Months
Ended
   Three Months
Ended
   Six Months
Ended
   Six Months
Ended
 
   June 27, 2026   June 28, 2025   June 27, 2026   June 28, 2025 
Cost of product revenues  $70,169   $86,569   $120,177   $226,006 
Research and development   191,611    124,345    328,957    242,065 
Selling, general and administrative   711,741    536,803    1,019,715    1,054,038 
Total  $973,521   $747,717   $1,468,849   $1,522,109 

 

Unrecognized compensation expense for non-vested restricted common stock as of June 27, 2026 totaled $9.9 million and is expected to be recognized over a weighted average period of approximately 2.25 years.

 

Stock Options

 

During the six months ended June 27, 2026, an option award for 724,638 shares of the Company’s common stock was granted to the Chief Executive Officer. These options have a strike price of $3.21 and vest over a 4 year period. During the six months ended June 27, 2026, the Company recorded incremental stock-based compensation of less than $0.3 million as a result of the granting of stock option awards. As of June 27, 2026, there was approximately $1.7 million of unrecognized compensation cost related to unvested options. The cost is expected to be recognized over a weighted average period of 3.3 years.

 

 

The fair value of this options award was estimated using the Black-Scholes model using the following assumptions and had the following fair values:

 

   Three Months
Ended
   Six Months
Ended
 
   June 27, 2026   June 27, 2026 
Average risk-free interest rate  4.00%  4.00%
Expected dividend yield   None    None 
Expected life (average, in years)   8.00    8.00 
Expected volatility   90.00%   90.00%
Weighted average exercise price  $3.21   $3.21 
Weighted average fair value  $2.07   $2.07 

 

The Company’s 2026 average expected volatility and average expected life is based on the average of the Company’s historical information. The risk-free rate is based on the rate of U.S. Treasury zero-coupon issues with a remaining term equal to the expected life of option grants. The Company has paid no dividends on its common stock in the past and does not anticipate paying any dividends in the future.

 

A summary of stock option activity for the period ended June 27, 2026 is as follows:

 

   Number of
Options
   Weighted
Average
Exercise Price
   Intrinsic
Value
 
Outstanding as of December 27, 2025   591,366   $1.76   $366,647 
Granted   724,638   $3.21     
Outstanding as of June 27, 2026   1,316,004   $2.56   $ 
Options exercisable as of June 27, 2026   312,342   $2.18   $